Thursday, July 21, 2016

BRIEF-AstraZeneca says antibiotic zavicefta met main goals in late-stage trial

* AstraZeneca's antibiotic zavicefta met primary endpoints

in phase III trial for treatment of hospital-acquired pneumonia

Source text for Eikon:

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)